222
Participants
Start Date
October 31, 2009
Primary Completion Date
July 31, 2011
Study Completion Date
December 31, 2011
exenatide once weekly
subcutaneous injection, 2mg, once a week
insulin detemir
subcutaneous injection, with dosage titrated according to the determir label and published titration schedule, once or twice a day
Research Site, Dublin
Research Site, Addlestone
Research Site, Bath
Research Site, Birmingham
Research Site, Blackburn
Research Site, Bournemouth
Research Site, Chippenham
Research Site, Derby
Research Site, Exeter
Research Site, High Wycombe
Research Site, Hull
Research Site, Leicester
Research Site, Liverpool
Research Site, London
Research Site, Manchester
Research Site, Merseyside
Research Site, Middlesbrough
Research Site, Newcastle
Research Site, Northampton
Research Site, Oldham
Research Site, Plymouth
Research Site, Portsmouth
Research Site, Sheffield
Research Site, Stevenage
Research Site, Suffolk
Research Site, Wakefield
Research Site, Wiltshire
Research Site, Aberdeen
Research Site, Dundee
Research Site, Carmathen
Research Site, Swansea
Research Site, Wrexham
Research Site, Leytonstone
Research Site, Livingston
Lead Sponsor
Eli Lilly and Company
INDUSTRY
AstraZeneca
INDUSTRY